D. S. Freestone

650 total citations
40 papers, 434 citations indexed

About

D. S. Freestone is a scholar working on Epidemiology, Infectious Diseases and Physiology. According to data from OpenAlex, D. S. Freestone has authored 40 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 15 papers in Infectious Diseases and 8 papers in Physiology. Recurrent topics in D. S. Freestone's work include Influenza Virus Research Studies (14 papers), Virology and Viral Diseases (11 papers) and Respiratory viral infections research (9 papers). D. S. Freestone is often cited by papers focused on Influenza Virus Research Studies (14 papers), Virology and Viral Diseases (11 papers) and Respiratory viral infections research (9 papers). D. S. Freestone collaborates with scholars based in United Kingdom, United States and Tanzania. D. S. Freestone's co-authors include D. A. J. Tyrrell, Gregory J. Lawrence, P. D. Walker, S Chinn, G. C. Schild, Frank Shann, R.J. Phillpotts, J. S. Willman, Paul G. Higgins and R.D. Ferris and has published in prestigious journals such as The Lancet, American Journal of Epidemiology and Transplantation.

In The Last Decade

D. S. Freestone

39 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. S. Freestone United Kingdom	13	286	135	100	44	40	40	434
Steven R. Mostow United States	15	401 1.4×	127 0.9×	103 1.0×	21 0.5×	68 1.7×	39	566
L. P. Van Voris United States	12	667 2.3×	285 2.1×	60 0.6×	20 0.5×	38 0.9×	14	753
Elena Buimovici‐Klein United States	16	336 1.2×	129 1.0×	134 1.3×	33 0.8×	55 1.4×	30	527
Harold T. Fuerst United States	11	128 0.4×	83 0.6×	39 0.4×	45 1.0×	26 0.7×	21	384
Stephen J. Lerman United States	13	215 0.8×	103 0.8×	70 0.7×	14 0.3×	23 0.6×	26	379
W. Paul Glezen United States	11	409 1.4×	148 1.1×	28 0.3×	22 0.5×	18 0.5×	14	521
Robert L. Atmar United States	6	372 1.3×	151 1.1×	33 0.3×	33 0.8×	36 0.9×	7	444
Janné Almeido-Hill United States	7	273 1.0×	141 1.0×	51 0.5×	29 0.7×	45 1.1×	8	460
M Piazza Italy	13	516 1.8×	164 1.2×	31 0.3×	11 0.3×	38 0.9×	47	753
Norio Iwaki Japan	13	727 2.5×	174 1.3×	74 0.7×	54 1.2×	97 2.4×	39	779

Countries citing papers authored by D. S. Freestone

Since Specialization

Citations

This map shows the geographic impact of D. S. Freestone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. S. Freestone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. S. Freestone more than expected).

Fields of papers citing papers by D. S. Freestone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. S. Freestone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. S. Freestone. The network helps show where D. S. Freestone may publish in the future.

Co-authorship network of co-authors of D. S. Freestone

This figure shows the co-authorship network connecting the top 25 collaborators of D. S. Freestone. A scholar is included among the top collaborators of D. S. Freestone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. S. Freestone. D. S. Freestone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Freestone, D. S.. (1994). Reflections on Pharmaceutical Company Project Portfolio Management. Drug Information Journal. 28(3). 641–646. 1 indexed citations

Freestone, D. S. & Hannah K Mitchell. (1993). Inappropriate publication of trial results and potential for allegations of illegal share dealing.. BMJ. 306(6885). 1112–1114. 7 indexed citations

Freestone, D. S.. (1988). The assessment of real hazards and appropriate counter‐measures: The clinician's view. Journal of Chemical Technology & Biotechnology. 43(4). 329–339.

Freestone, D. S.. (1985). The need for new antiviral agents. Antiviral Research. 5(6). 307–324. 10 indexed citations

Phillpotts, R.J., et al.. (1984). Intranasal Lymphoblastoid Interferon ("Well fer on") Prophylaxis Against Rhinovirus and Influenza Virus in Volunteers. Journal of Interferon Research. 4(4). 535–541. 29 indexed citations

Finter, N. B. & D. S. Freestone. (1983). Neurological effects of recombinant human interferon. BMJ. 286(6370). 1054.7–1055. 2 indexed citations

Blamey, R.W., J. D. Briggs, J E Castro, et al.. (1983). MEDICAL RESEARCH COUNCIL TRIAL OF ANTILYMPHOCYTE GLOBULIN IN RENAL TRANSPLANTATION. Transplantation. 35(6). 539–545. 14 indexed citations

Freestone, D. S., et al.. (1980). Comparison of antibody responses and virus shedding following administration of trivalent oral poliomyelitis vaccines prepared either in monkey kidney or human diploid cell substrates. Journal of Hygiene. 84(1). 17–28. 2 indexed citations

Freestone, D. S.. (1979). Vaccination against rubella in Britain: benefits and risks.. PubMed. 43. 339–48. 5 indexed citations

10.

Ferris, R.D., et al.. (1979). Antibody responses to vaccination with WRL 105 strain live influenza vaccine in previously vaccinated and unvaccinated volunteers. Journal of Hygiene. 82(3). 489–495. 2 indexed citations

11.

Lawrence, Gregory J., Frank Shann, D. S. Freestone, & P. D. Walker. (1979). PREVENTION OF NECROTISING ENTERITIS IN PAPUA NEW GUINEA BY ACTIVE IMMUNISATION. The Lancet. 313(8110). 227–230. 47 indexed citations

12.

Morris, C. A., et al.. (1976). COMPARISON OF ANTIBODY RESPONSES AND REACTIVITY OF "ALICE" AND WRL 105 STRAIN LIVE INFLUENZA VACCINES. The Lancet. 307(7969). 1118–1120. 1 indexed citations

13.

Freestone, D. S.. (1976). PRECLINICAL DATA SUPPORTING FIRST CLINICAL TRIALS OF NEW INACTIVATED VACCINES. The Lancet. 308(7989). 786–789. 2 indexed citations

14.

Freestone, D. S., et al.. (1976). WRL 105 strain live attenuated influenza vaccine; comparison of one and two dose schedules. Journal of Hygiene. 77(3). 327–332. 8 indexed citations

15.

Freestone, D. S., et al.. (1975). Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six years. Journal of Hygiene. 75(3). 407–412. 7 indexed citations

16.

Morris, C. A., et al.. (1975). RECOMBINANT WRL 105 STRAIN LIVE ATTENUATED INFLUENZA VACCINE. The Lancet. 306(7927). 196–199. 24 indexed citations

17.

Freestone, D. S.. (1974). Programmes for the prevention of rubella during pregnancy by active immunization. Journal of Epidemiology & Community Health. 28(4). 258–264. 4 indexed citations

18.

Freestone, D. S., et al.. (1972). Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2/Hong Kong/68 (H3N2) influenza vaccines.. Epidemiology and Infection. 70(3). 34 indexed citations

19.

Freestone, D. S.. (1971). Protection by inactivated split antigen influenza vaccine.. Medical officer. 125(3). 1 indexed citations

20.

Freestone, D. S.. (1965). POSSIBLE RETROPERITONEAL FIBROSIS AND METHYSERGIDE. The Lancet. 285(7396). 1168–1168. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact